New York Times Comes Clean on Cholesterol Lowering Drugs

Every now and then, the truth shoves its way into the popular media. Hopefully all the Aunt Helga's and Uncle Bob's are reading. This comes direct from The New York Times:

"When the Food and Drug Administration approved a new type of cholesterol-lowering medicine in 2002, it did so on the basis of a handful of clinical trials covering a total of 3,900 patients. None of the patients took the medicine for more than 12 weeks, and the trials offered no evidence that it had reduced heart attacks or cardiovascular disease, the goal of any cholesterol drug."


Save a life, and show the whole story with The Hidden Truth about Cholesterol Lowering Drugs. Check it put at Amazon :Hidden Truth about Cholesterol-Lowering Drugs .You know how important is it.





Via:Wellness Tips Blog

Strong Heart

Strengthening a Broken Heart
The National Institute of Health (NIH) sponsored a two day seminar entitled "Carnitine [acetyl-L- carnitine AKA ALCAR]: The Science behind a Conditionally Essential Nutrient". These were the highlights:

Those who had suffered from a heart attack, ALCAR supplementation (2-3 g/day over 4-8 weeks) resulted in a reduction in the amount of damage to the heart muscle.

ALCAR reduced the incidence of angina and cardiac arrhythmias as well as the need for anti-angina and anti-arrhythmic medications.ALCAR (2g/ day for 6 months) increased exercise capacity among the elderly and patients with angina.Natural sources of carnitine include foods of animal origin, such as meat and dairy products.

Check out this amazing wellness product :



TwinLab Acetyl L-Carnitine, 500 mg, Capsule, 120-Count Bottle
The unique blend of vitamins, extracts, herbal stimulants, and nootropic smart drugs make it powerful in facilitation of body fat loss, boosting energy, and cases of attention deficit hyperactivity disorder.


Also Check out:What's Your Risk for Heart Disease?